Optimal thrombolytic therapy: for whom, when, how.
Here are criteria for patient selection, as well as contraindications for intravenous thrombolysis, the advantages and disadvantages of available drugs, and protocols for administration of each.
Anderson
J L
JL
University of Utah School of Medicine, Salt Lake City.
D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy
D005343:Fibrinolytic Agents